Cytokine Profile and Immunomodulation in Asymptomatic Human T-Lymphotropic Virus Type 1–Infected Blood Donors
- 1 May 2001
- journal article
- research article
- Published by Wolters Kluwer Health in JAIDS Journal of Acquired Immune Deficiency Syndromes
- Vol. 27 (1) , 1-6
- https://doi.org/10.1097/00042560-200105010-00001
Abstract
Summary:The modulation of the immune response has been used as therapy for clinical disorders associated with human T-lymphotropic virus type 1 (HTLV-1) infection. In this study, the cytokine profile was evaluated in 26 asymptomatic HTLV-1 blood donors. Additionally, both the cell responsible for producing interferon-γ (IFN-γ) and the role of exogenous interleukin (IL)-10 in downregulating IFN-γ production were studied. Cytokine levels were determined in supernatants of unstimulated lymphocyte cultures by enzyme-linked immunosorbent assay. The levels of IFN-γ, tumor necrosis factor-α, IL-5, and IL-10 were higher in supernatants of the lymphocyte cultures taken from HTLV-1-infected donors than in those taken from healthy subjects. Although depletion of CD8+ T cells and natural killer cells did not affect IFN-γ production, depletion of CD4+ T cells significantly decreased IFN-γ production. Furthermore, at a concentration of 2 ng/ml, IL-10 had only a minimum effect on IFN-γ production, although at high concentrations (100 ng/ml), IL-10 decreased IFN-γ production by 50% in HTLV-1-infected individuals. These data indicate that both T helper 1 and T helper 2 cytokines are elevated in HTLV-1 infection and that IL-10 in high concentrations modulates IFN-γ production in these patients. Address correspondence to Edgar M. Carvalho, Serviço de Imunologia, HUPES, 5° andar, Rua João das Botas s/n, Canela-40.110.160, Salvador, Bahia, Brazil; e-mail: [email protected] or [email protected] Manuscript received October 10, 2000; accepted March 2, 2001. © 2001 Lippincott Williams & Wilkins, Inc.Keywords
This publication has 13 references indexed in Scilit:
- Interferon‐γ and Interleukin‐4 Responses in Relation to Serum IgE Levels in Persons Infected with Human T Lymphotropic Virus Type I andStrongyloides stercoralisThe Journal of Infectious Diseases, 1998
- Distribution of human T‐lymphotropic virus type I among blood donors: a nationwide Brazilian studyTransfusion, 1997
- Cytotoxicity in patients with different clinical forms of Chagas’ diseaseClinical and Experimental Immunology, 1996
- Interleukin‐2 Prevents Programmed Cell Death in Adult T‐Cell Leukemia CellsJapanese Journal of Cancer Research, 1993
- Transactivation of interleukin 2 and its receptor induces immune activation in human T-cell lymphotropic virus type I-associated myelopathy: pathogenic implications and a rationale for immunotherapy.Proceedings of the National Academy of Sciences, 1990
- Immunological studies in tropical spastic paraparesisAnnals of Neurology, 1990
- Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones.The Journal of Experimental Medicine, 1989
- SPONTANEOUS LYMPHOCYTE PROLIFERATION IN SYMPTOM-FREE HTLV-I POSITIVE JAMAICANSThe Lancet, 1989
- Antigen-specific immunosuppression in visceral leishmaniasis is cell mediated.Journal of Clinical Investigation, 1989
- Alteration of T-Cell Functions by Infection with HTLV-I or HTLV-IIScience, 1984